Inhibition of platelet aggregation with intravenous and oral administration of a carboprostacyclin analogue, 15-cyclopentyl-ω-pentanor-5(E)-carbacyclin (ONO 41483) in man
- 31 January 1983
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes and Medicine
- Vol. 10 (1) , 53-64
- https://doi.org/10.1016/s0262-1746(83)80020-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effect of PGE1, PGE2 and PGI2 on ventricular arrhythmias during myocardial infarction in conscious dogs: Relation to infarct sizeProstaglandins and Medicine, 1981
- Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.Circulation, 1981
- Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in manProstaglandins and Medicine, 1981
- Platelet and other effects of carboprostacyclin - A stable prostacyclin analogueProstaglandins and Medicine, 1980
- Hypertension and propranolol therapy: Effect on blood pressure, plasma catecholamines and platelet aggregationThe American Journal of Cardiology, 1980
- PROSTACYCLIN GENERATION IN ATHEROSCLEROTIC ARTERIESThe Lancet, 1979
- Platelet aggregation across the myocardial vascular bed in man: I. Normal versus diseased coronary arteriesThrombosis Research, 1979
- Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial IschemiaScience, 1978
- ELEVATED β-THROMBOGLOBULIN LEVELS AND CIRCULATING PLATELET AGGREGATES IN DIABETIC MICROANGIOPATHYThe Lancet, 1978
- A NEW METHOD FOR THE QUANTITATIVE DETECTION OF PLATELET AGGREGATES IN PATIENTS WITH ARTERIAL INSUFFICIENCYThe Lancet, 1974